Used in cancer immunotherapy research, particularly as a small molecule inhibitor that targets immune checkpoint pathways. It enhances T-cell activation by blocking the PD-L1/PD-1 interaction, which helps restore anti-tumor immune responses. Shows potential in preclinical studies for improving the efficacy of immune-based treatments against solid tumors. Also utilized as a chemical probe to study immune evasion mechanisms in tumor microenvironments.